AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2905148 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg and 160 mg
Number of subjects: 12
Study 30015510 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial controlled weightbearing at 40% body weight with crutches for 6 weeks
Number of subjects: 39
Study 30015510 — intervention group
Group type: COMPARATOR
Intervention: Nonweightbearing for 6 weeks
Number of subjects: 39
Study 28595694 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred stenting
Number of subjects: 510
Study 28595694 — intervention group
Group type: COMPARATOR
Intervention: Immediate stent implantation
Number of subjects: 510
Study 28595694 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred stenting (in subgroup with stent length ≥24 mm)
Number of subjects: 510
Study 28595694 — intervention group
Group type: COMPARATOR
Intervention: Immediate stent implantation (in subgroup with stent length ≥24 mm)
Number of subjects: 510
Study 25758769 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin (5 or 2.5 mg daily)
Number of subjects: 16592
Study 25758769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16592
Study 24060088 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine plus dexamethasone (RD)
Number of subjects: 200
Study 24060088 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine alone (R)
Number of subjects: 200
Study 19967572 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy including biofeedback tools (CBT-B)
Number of subjects: 128
Study 19967572 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 128
Study 19967572 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 128
Study 18384187 — intervention group
Group type: EXPERIMENTAL
Intervention: C index including ties (Ctied,in)
Number of subjects: 0
Study 18384187 — intervention group
Group type: EXPERIMENTAL
Intervention: C index excluding ties (Ctied,out)
Number of subjects: 0
Study 18384187 — intervention group
Group type: EXPERIMENTAL
Intervention: Both C indices
Number of subjects: 0
Study 18384187 — intervention group
Group type: EXPERIMENTAL
Intervention: Average value of the two C indices
Number of subjects: 0
Study 16780741 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive pressure ventilation (PPV) for 2 - 5 days
Number of subjects: 105
Study 16780741 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 105
Study 14693300 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 155
Study 14693300 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil
Number of subjects: 155
Study 14693300 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil
Number of subjects: 155
Study 10812259 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine, bolus 150 microg/kg + infusion 1 microg/kg per min and 0.5 microg/kg per min
Number of subjects: 12
Study 10812259 — intervention group
Group type: EXPERIMENTAL
Intervention: ketamine, bolus 60 microg/kg + infusion 6 microg/kg per min and 3 microg/kg per min
Number of subjects: 12
Study 10812259 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 8857004 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 3145
Study 8857004 — intervention group
Group type: COMPARATOR
Intervention: Thrombolytic therapy
Number of subjects: 3145
Study 1848072 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12
Study 1848072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6317726 — intervention group
Group type: EXPERIMENTAL
Intervention: Directive patient-education group
Number of subjects: 36
Study 6317726 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 31455792 — intervention group
Group type: COMPARATOR
Intervention: 30-min moderate-intensity exercise before studying word pairs
Number of subjects: 0
Study 31455792 — intervention group
Group type: COMPARATOR
Intervention: 30-min moderate-intensity exercise after studying word pairs
Number of subjects: 0
Study 31455792 — intervention group
Group type: COMPARATOR
Intervention: 30-min moderate-intensity exercise (before or after encoding)
Number of subjects: 0
Study 30522501 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept 125 mg weekly for 24 weeks
Number of subjects: 424
Study 30522501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 424
Study 27494516 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular glucocorticoid injections (IAGCIs)
Number of subjects: 99
Study 24833315 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation combined with early intervention service (EIS)
Number of subjects: 117
Study 24833315 — intervention group
Group type: COMPARATOR
Intervention: EIS alone
Number of subjects: 117
Study 23264279 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered Air-Purifying Respirator (PAPR)
Number of subjects: 20
Study 23264279 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Pressure Respirator (NPR)
Number of subjects: 20
Study 23264279 — intervention group
Group type: COMPARATOR
Intervention: Control (no respirator)
Number of subjects: 20
Study 20979824 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 37.5 mg/m² on days 1 and 8, oral capecitabine 950 mg/m² twice daily on days 1-14 (Group A)
Number of subjects: 83
Study 20979824 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m² on days 1, oral capecitabine 950 mg/m² twice daily on days 1-14 (Group B)
Number of subjects: 83
Study 20979824 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall clinical response rate for all groups
Number of subjects: 83
Study 20979824 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Group A and Group B
Number of subjects: 83
Study 18570597 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg plus verapamil sustained release/trandolapril 180/2 mg
Number of subjects: 54
Study 18570597 — intervention group
Group type: COMPARATOR
Intervention: Verapamil sustained release/trandolapril 180/2 mg
Number of subjects: 54
Study 16533677 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined visit testing (DSS at the same time as other tests)
Number of subjects: 100
Study 16533677 — intervention group
Group type: COMPARATOR
Intervention: Separate visit testing (DSS conducted separately from other tests)
Number of subjects: 100
Study 12593526 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclometasone dipropionate (BDP) suspension for nebulization 2,400 microg day(-1) b.i.d. (n = 103)
Number of subjects: 205
Study 12593526 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) suspension for nebulization 2,000 microg day(-1) b.i.d. (n = 102)
Number of subjects: 205
Study 10578972 — intervention group
Group type: EXPERIMENTAL
Intervention: NMP179 monoclonal antibody
Number of subjects: 261
Study 8851320 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A: 6 x 0.5 ml per kg body weight
Number of subjects: 12
Study 8851320 — intervention group
Group type: COMPARATOR
Intervention: Regimen B: 0.25 ml per kg body weight at gastric pH < 3
Number of subjects: 12
Study 1654365 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotavirus vaccine strain M37 (10^5-pfu dose) in adults
Number of subjects: 48
Study 1654365 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotavirus vaccine strain M37 (10^4-pfu dose) in infants and children
Number of subjects: 48
Study 1654365 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotavirus vaccine strain M37 (10^5-pfu dose) in infants
Number of subjects: 48
Study 1654365 — intervention group
Group type: COMPARATOR
Intervention: Rotavirus vaccine strain M37
Number of subjects: 48
Study 6347162 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: vincristine, adriamycin, and dimethyl triazeno imidazole carboxamide (DIC)
Number of subjects: 27
Study 6347162 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: VM‐26, adriamycin, and DIC
Number of subjects: 27
Study 6347162 — intervention group
Group type: EXPERIMENTAL
Intervention: Long bone lesions
Number of subjects: 27
Study 6347162 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat bone lesions
Number of subjects: 27
Study 29756483 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope and modified Magill forceps (Group M)
Number of subjects: 70
Study 29756483 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 70
Study 28034414 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS reminders regarding adherence to a healthy diet, medication, and smoking cessation
Number of subjects: 160
Study 28034414 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (received general messages)
Number of subjects: 160
Study 28034414 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 160
Study 28034414 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS reminders
Number of subjects: 160
Study 25882510 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy with Solitaire stent retriever and medical therapy (including intravenous alteplase when eligible)
Number of subjects: 206
Study 25882510 — intervention group
Group type: COMPARATOR
Intervention: Control group (medical therapy alone)
Number of subjects: 206
Study 23192416 — intervention group
Group type: COMPARATOR
Intervention: Ankle Foot Orthosis (AFO)
Number of subjects: 12
Study 23192416 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous Peroneal Nerve Stimulator (tPNS)
Number of subjects: 12
Study 23192416 — intervention group
Group type: COMPARATOR
Intervention: AFO
Number of subjects: 12
Study 21446902 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg po qD)
Number of subjects: 10
Study 21446902 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 17412718 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational programme providing verbal and written advice about exclusive breast-feeding for 6 months
Number of subjects: 89
Study 17412718 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational programme)
Number of subjects: 89
Study 16221754 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk thistle (900 mg daily for 14 days)
Number of subjects: 16
Study 16221754 — intervention group
Group type: EXPERIMENTAL
Intervention: Black cohosh (40 mg daily for 14 days)
Number of subjects: 16
Study 16221754 — intervention group
Group type: COMPARATOR
Intervention: Rifampin (600 mg daily for 7 days)
Number of subjects: 16
Study 16221754 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin (1000 mg daily for 7 days)
Number of subjects: 16
Study 12656875 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmandibular implant according to Bosker
Number of subjects: 60
Study 12656875 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmentation of the mandible followed by four endosseous implants
Number of subjects: 60
Study 12656875 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertion of four short endosseous implants
Number of subjects: 60
Study 12656875 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 60
Study 12596948 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ciprofloxacin hydrochloride
Number of subjects: 88
Study 12596948 — intervention group
Group type: COMPARATOR
Intervention: Topical gentamicin sulfate
Number of subjects: 88
Study 9480180 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological protection
Number of subjects: 20
Study 8494079 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine treatment
Number of subjects: 60
Study 8494079 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine treatment after dosage increases or disulfiram
Number of subjects: 60
Study 8494079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 3095641 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 125 mg intramuscular dose
Number of subjects: 122
Study 3095641 — intervention group
Group type: COMPARATOR
Intervention: Kanamycin 75 mg intramuscular dose plus topical gentamicin for 7 days
Number of subjects: 122
Study 3095641 — intervention group
Group type: COMPARATOR
Intervention: Kanamycin 75 mg intramuscular dose plus topical tetracycline for 7 days
Number of subjects: 122
Study 3095641 — intervention group
Group type: COMPARATOR
Intervention: Kanamycin 75 mg intramuscular dose
Number of subjects: 122
Study 30200092 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid tablet 0.4 mg/kg taken orally once a day for 4 days before surgery
Number of subjects: 40
Study 30200092 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 40
Study 27348542 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg triptoreline
Number of subjects: 98
Study 27348542 — intervention group
Group type: COMPARATOR
Intervention: Standard luteal support with vaginal micronised progesterone
Number of subjects: 98
Study 23992038 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (SMS text messages, e-mails, smartphone applications, Internet forums)
Number of subjects: 51
Study 23992038 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention
Number of subjects: 51
Study 23992038 — intervention group
Group type: COMPARATOR
Intervention: Control (printed diet booklet)
Number of subjects: 51
Study 22483419 — intervention group
Group type: EXPERIMENTAL
Intervention: Total dairy intake
Number of subjects: 33625
Study 22483419 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented dairy
Number of subjects: 33625
Study 22483419 — intervention group
Group type: EXPERIMENTAL
Intervention: Total dairy (among participants without hypertension)
Number of subjects: 33625
Study 22483419 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dairy (among participants without hypertension)
Number of subjects: 33625
Study 22483419 — intervention group
Group type: EXPERIMENTAL
Intervention: Total dairy and low-fat dairy (among hypertensive participants)
Number of subjects: 33625
Study 21740277 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyeliner adjunct to IPL
Number of subjects: 62
Study 21740277 — intervention group
Group type: COMPARATOR
Intervention: Color-dye adjunct to IPL
Number of subjects: 62
Study 21740277 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyeliner group
Number of subjects: 62
Study 21740277 — intervention group
Group type: COMPARATOR
Intervention: Color-dye group
Number of subjects: 62
Study 18295626 — intervention group
Group type: EXPERIMENTAL
Intervention: Arc-RAD
Number of subjects: 30
Study 18295626 — intervention group
Group type: COMPARATOR
Intervention: C-RAD
Number of subjects: 30
Study 17027354 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg mifepristone
Number of subjects: 399
Study 17027354 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg mifepristone
Number of subjects: 399
Study 17027354 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg mifepristone
Number of subjects: 399
Study 17027354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study 12740742 — intervention group
Group type: EXPERIMENTAL
Intervention: Runners (increased training volume by 16%)
Number of subjects: 17
Study 12740742 — intervention group
Group type: COMPARATOR
Intervention: Nonathletes (sedentary controls)
Number of subjects: 17
Study 11116697 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Strategy (DS)
Number of subjects: 77
Study 11116697 — intervention group
Group type: EXPERIMENTAL
Intervention: Tendency Oriented Perimetry (TOP)
Number of subjects: 77
Study 11116697 — intervention group
Group type: COMPARATOR
Intervention: Normal Strategy (NS)
Number of subjects: 77
Study 8627046 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethambutol
Number of subjects: 0
Study 8627046 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofazimine
Number of subjects: 0
Study 8627046 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 0
Study 8627046 — intervention group
Group type: COMPARATOR
Intervention: Control (bacteriologic response in mice)
Number of subjects: 0
Study 1351489 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol, 200 micrograms
Number of subjects: 12
Study 1351489 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol, 12 micrograms
Number of subjects: 12
Study 1351489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2423337 — intervention group
Group type: EXPERIMENTAL
Intervention: beta-sitosteryl beta-D-glucoside (WA184) at a dose of 0.3 mg/day
Number of subjects: 53
Study 2423337 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 53
Study 29531924 — intervention group
Group type: EXPERIMENTAL
Intervention: PGB 75 mg daily
Number of subjects: 71
Study 29531924 — intervention group
Group type: EXPERIMENTAL
Intervention: PGB 75 mg daily and Met 500 mg daily for 3 months
Number of subjects: 71
Study 27538513 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogic breathing (YB) for 20 minutes (two exercises of 10 minutes each)
Number of subjects: 20
Study 27538513 — intervention group
Group type: COMPARATOR
Intervention: Attention Control (AC) - reading a text for 20 minutes
Number of subjects: 20
Study 23644549 — intervention group
Group type: EXPERIMENTAL
Intervention: golimumab 50 mg every 4 weeks
Number of subjects: 356
Study 23644549 — intervention group
Group type: EXPERIMENTAL
Intervention: golimumab 100 mg every 4 weeks
Number of subjects: 356
Study 23644549 — intervention group
Group type: COMPARATOR
Intervention: placebo crossover
Number of subjects: 356
Study 23644549 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without baseline syndesmophytes
Number of subjects: 356
Study 23644549 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with baseline CRP levels <1.5 mg/dl
Number of subjects: 356
Study 22575398 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency portacaval shunt (EPCS)
Number of subjects: 211
Study 22575398 — intervention group
Group type: COMPARATOR
Intervention: Emergency endoscopic therapy (EST)
Number of subjects: 211
Study 20157661 — intervention group
Group type: EXPERIMENTAL
Intervention: Light curing after inlay insertion
Number of subjects: 48
Study 20157661 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual curing adhesive and luting composite (LC)
Number of subjects: 48
Study 20157661 — intervention group
Group type: COMPARATOR
Intervention: Separate light polymerization of XP Bond
Number of subjects: 48
Study 18381571 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg sc every 6 months
Number of subjects: 332
Study 18381571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study 16723055 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg morphine sulphate orally every 4 h for 24 h
Number of subjects: 60
Study 16723055 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg morphine sulphate orally every 4 h for 24 h
Number of subjects: 60
Study 16723055 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 16723055 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg morphine sulphate orally every 4 h for 16 h (pharmacokinetic study)
Number of subjects: 60
Study 12855090 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential-Cognitive Therapy (ECT) - 8 sessions
Number of subjects: 12
Study 12855090 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) - 12 sessions
Number of subjects: 12
Study 12855090 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 12
Study 10777986 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low Density Lipoprotein (VLDL) and High Density Lipoprotein (HDL) levels
Number of subjects: 600
Study 10777986 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical model of population incidence of DM
Number of subjects: 600
Study 9208626 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole (40 mg/d, tapered to 20 mg/d after two weeks)
Number of subjects: 32
Study 9208626 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole combined with Dexamethasone (Dex, 6 mg/d, reduced to 4.5 mg/d on the 5th day and to 2.25 mg/d two weeks after treatment)
Number of subjects: 32
Study 9208626 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 normals)
Number of subjects: 32
Study 1597229 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (90 mg t.i.d.)
Number of subjects: 20
Study 1597229 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallopamil (50 mg t.i.d.)
Number of subjects: 20
Study 1597229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6397331 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide (2 sprays to each nostril twice daily for 7 weeks)
Number of subjects: 69
Study 6397331 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (2 sprays to each nostril twice daily for 7 weeks)
Number of subjects: 69
Study 31531996 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine Group (CG) - received creatine plus maltodextrin, 1st week: 20 g/day of creatine plus 20 g/day of maltodextrin and 2nd-4th weeks: 5 g/day of creatine plus 5 g/day of maltodextrin
Number of subjects: 30
Study 31531996 — intervention group
Group type: COMPARATOR
Intervention: Placebo Group (PG) - received maltodextrin, 1st week: 40 g/day and 2nd-4th weeks: 10 g/day
Number of subjects: 30
Study 30566027 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Progressive MS (PPMS) patients
Number of subjects: 1889
Study 30566027 — intervention group
Group type: COMPARATOR
Intervention: SELs
Number of subjects: 1889
Study 28122280 — intervention group
Group type: EXPERIMENTAL
Intervention: Chan-Chuang qigong (21-day programme)
Number of subjects: 100
Study 28122280 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 25479146 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine (nerve blocks and incision infiltration)
Number of subjects: 60
Study 25479146 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (control group)
Number of subjects: 60
Study 24284609 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation containing B-vitamins
Number of subjects: 138
Study 24284609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 24284609 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation
Number of subjects: 138